INDIGO Biosciences

INDIGO Biosciences offers products and services focused on nuclear receptors, which comprise of therapeutic drug targets.

INDIGO Biosciences, Inc. was founded in 2005 in State College, PA. It remains a privately held biosciences company offering products and services focused on nuclear receptors, which comprise a major class of therapeutic drug targets. The Company's two founders, Dr. Jack Vanden Heuvel and Dr. Blake Peterson, leveraged their collective expertise's in nuclear receptor biology, toxicology, medicinal chemistry and molecular biology to establish the core platform technology of The Company.